Pharma lobbyists flooded Maryland to block a drug-pricing bill. Opponents pushed back — and won
(By Lev Facher for STAT) ANNAPOLIS, Md. — The drug industry has long been seen as invincible in this small
Read More
Part D/Prescription Drugs
The Blame Game: Everyone And No One Is Raising Insulin Prices
(By Rachel Bluth for Kaiser Health News) A casual observer of Wednesday’s House Energy and Commerce subcommittee hearing might think
Read MorePBMs sidestep the Senate’s tough questions — but lawmakers hint at legislation
(By Nicholas Florko for STAT) WASHINGTON — The much-maligned pharmacy middlemen escaped largely unscathed during a high-profile congressional hearing Tuesday
Read MoreOptumRx: 5 costly drugs coming this year
(By Alia Paavola for Becker’s Hospital Review) OptumRx released a list of five new and potentially expensive treatments coming to
Read MoreConsumers Rejected Drug Plan That Mirrors Trump Administration Proposal
(By Sydney Lupkin for Kaiser Health News) Unraveling how much of a prescription drug price gets swallowed by “middlemen” is
Read MoreDon’t make this Medicare mistake
According to TD Ameritrade, 44 percent people believe it will cover the bulk of their medical expenses in retirement; however,
Read MoreThis week, five pharmacy ‘middlemen’ head to Capitol Hill’s hot seat. Some of them have an easier defense than others
(By Nicholas Florko for STAT) WASHINGTON — President Trump has blasted them as “middlemen,” known for their “dishonest double dealing.”1
Read More3 drugmakers pay nearly $123M to settle kickback claims
(By Alia Paavola for Becker’s Hospital Review) Three drugmakers — Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals — have agreed to pay $122.6
Read MoreHRSA launched a website that will allow safety-net hospitals to view 340B
The Health Resource and Services Administration (HRSA) launched a website that enables safety-net hospitals to identify the maximum amount that
Read MoreBiotech accuses Dr. Soon-Shiong of orchestrating a ‘catch and kill’ scheme to protect cancer drug
(By Alia Paavola for Becker’s Hospital Review) A California biotech claims that the controversial billionaire biotech entrepreneur Patrick Soon-Shiong, MD,
Read More